Dr. Agarwal's Health Care IPO
Historical offer record. This offer is closed for applications. Prices and subscriptions describe the past offer; GMP observations are unofficial past records, not current quotes or listing predictions.
Data provider: FinAPI. This is a third-party summary, not an official prospectus. Read our data limitations and editorial policy.
No GMP observations are available for this historical offer record. No premium or listing-gain estimate is shown.
Price band
₹382 – ₹402
Lot size
35 shares
Offer application amount
₹14,070
Issue size
₹3027.26 Cr
Historical offer amount for 1 lot at the upper issue price. Confirm the lot size and application terms in the issuer prospectus.
Reported IPO schedule
| Open date | 29 Jan 2025 |
| Close date | 31 Jan 2025 |
| Allotment finalisation | 3 Feb 2025 |
| Refund initiation | 4 Feb 2025 |
| Shares credited to demat | 4 Feb 2025 |
| Reported listing date | 4 Feb 2025 |
Issue size
About Dr. Agarwal's Health Care
Dr. Agarwal’s Health Care Limited founded in 2010, is one of the growing companies in the field of eye care-related pharmaceutical products. The company portfolio consists of a wide range of products and eye care services such as cataract, refractive, surgeries, consultations, diagnoses, non-surgical treatments, opticals, contact lenses, and many other accessories. Due to its exceptional operational history, the goal is to fulfill the needs of its patients in the eye care treatment journey making them feel safe and confident.
Company summary supplied by FinAPI. Read the prospectus for the issuer's disclosures and audited financials.
Offer documents and primary references
Read the issuer's offer document and any corrigenda for the full disclosures. A third-party details page is a summary; SEBI filing access does not imply an endorsement of the offer or this website.
IPO information is sourced from public feeds and shown for general information only. It is not a recommendation to apply for this or any IPO. IPOs are equity investments and carry market risk; listing gains are not guaranteed and SME IPOs are especially volatile. Grey Market Premium (GMP) is unofficial and not endorsed by SEBI or the exchanges. Equity IPOs are applied for through a demat and trading account, not through mutual fund distribution services. Read the RHP and consult a SEBI-registered investment adviser before investing.